Center for Health Policy | Science and Technology Policy | Journal

Unproven Stem Cell Interventions: A Global Public Health Problem Requiring Global Deliberation

June 9, 2021 | Kirstin R.W. Matthews, Zubin Master, Mohamed Abou-el-Enein
Blue stem cell under microscope

Table of Contents

Author(s)

Mohamed Abou-el-Enein

Executive Director, Joint USC/CHLA Cell Therapy Program, Keck School of Medicine

Share this Publication

  • Print This Publication
  • Cite This Publication

    Master Z, Matthews KRW, Abou-El-Enein M. Unproven stem cell interventions: A global public health problem requiring global deliberation. Stem Cell Reports. 2021 Jun 8;16(6):1435-1445. doi: 10.1016/j.stemcr.2021.05.004. PMID: 34107243; PMCID: PMC8190665.

    Copy Citation

The unproven stem cell intervention (SCI) industry is a global health problem. Despite efforts of some nations, the industry continues to flourish. In this paper, we call for a global approach and the establishment of a World Health Organization (WHO) Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. The WHO committee can harmonize national regulations; promote regulatory approaches responsive to unmet patient needs; and formulate an education campaign against misinformation. Fostering an international dialog and developing recommendations that can be adopted by member states would effectively address the global market of unproven SCIs.

Read the full piece in Stem Cell Reports.  

https://doi.org/10.1016/j.stemcr.2021.05.004

Related Research